This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on September 1, 2003. The length of the article is 5655 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Hybridon receives patent for orally administering second generation antisense oligonucleotides.
Publication:BIOTECH Patent News (Newsletter)
Date: September 1, 2003
Publisher: Biotech Patent News
Volume: 17 Issue: 9
Distributed by Thomson Gale
Hybridon receives patent for orally administering second generation antisense oligonucleotides.: An article from: BIOTECH Patent News
📄 Viewing lite version
Full site ›
Book Details
PublisherBiotech Patent News
ISBN / ASINB0008E92BQ
ISBN-13978B0008E92B9
AvailabilityAvailable for download now
MarketplaceUnited States 🇺🇸